The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis

American Journal of Rhinology

Volumn 22, Issue 2, 2008, Pages 182-187

  Harvey, Richard J ^a,b   Kanagalingam, Jeeves ^a   Lund, Valerie J ^a  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Dermoplasty; Epistaxis; Hereditary hemorrhagic telangiectasia; KTP laser; Osler Weber Rendu; Septodermoplasty; Skin graft

Indexed keywords

PHOSPHATE; POTASSIUM TITANYL PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EPISTAXIS; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; RENDU OSLER WEBER DISEASE; SEPTODERMOPLASTY; SURGICAL TECHNIQUE;

EPISTAXIS; FEMALE; HUMANS; LASER THERAPY; LASERS, SOLID-STATE; MALE; NASAL SEPTUM; RETROSPECTIVE STUDIES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME;

EID: 42449163015     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2008.22.3145     Document Type: Article

References (30)

1. Bird RM, Hammarsten JF, Marshall RA, and Robinson RR. A family reunion: A study of hereditary hemorrhagic telangiectasia. N Engl J Med 257:105-109, 1957.
2. Gallitelli M, Pasculli G, Fiore T, et al. Emergencies in hereditary haemorrhagic telangiectasia. QJM 99:15-22, 2006.
3. Folz BJ, Tennie J, Lippert BM, and Werner JA. Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease. Rhinology 43:40-46, 2005.
4. Siegel MB, Keane WM, Atkins JF Jr, and Rosen MR. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 105:675-679, 1991.
5. Lennox PA, Hitchings AE, Lund VJ, and Howard DJ. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19:71-74, 2005.
6. Begbie ME, Wallace GMF, and Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): A view from the 21st century. Postgrad Med J 79:18-24, 2003.
7. Byahatti SV, Rebeiz EE, and Shapshay SM. Hereditary hemorrhagic telangiectasia: What the otolaryngologist should know. Am J Rhinol 11:55-62, 1997.
8. Assar O, Friedman CM, and White RI Jr. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 101:977-980, 1991.
9. Lund VJ, and Howard DJ. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 13:319-322, 1999.
10. Sadick H, Nairn R, Oulmi J, et al. Plasma surgery and topical estriol: Effects on the nasal mucosa and long-term results in patients with Osier's disease. Otolaryngol Head Neck Surg 129:233-238, 2003.
11. Lennox PA, Harries M, Lund VJ, and Howard DJ. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia. J Laryngol Otol 111:34-37, 1997.
12. Shah RK, Dhingra JK, and Shapshay SM. Hereditary hemorrhagic telangiectasia: A review of 76 cases. Laryngoscope 112:767-773, 2002.
13. Kuhnel TS, Wagner BH, Schurr CP, and Strutz J. Clinical strategy in hereditary hemorrhagic telangiectasia. Am J Rhinol 19:508-513, 2005.
14. Levine HL. Endoscopy and the KTP/532 laser for nasal sinus disease. Ann Otol Rhinol Laryngol 98:46-51, 1989.
15. Harries PG, Brockbank MJ, Shakespeare PG, and Carruth JA. Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser. J Laryngol Otol 111:1038-1041, 1997.
16. Elden L, Montanera W, Terbrugge K, et al. Angiographic embolization for the treatment of epistaxis: A review of 108 cases. Otolaryngol Head Neck Surg 111:44-50, 1994.
17. Golding-Wood PH. The role of arterial ligation in intractable epistaxis. J Laryngol Otol Suppl 8:120-122, 1983.
18. Ross DA, and Nguyen DB. Inferior turbinectomy in conjunction with septodermoplasty for patients with hereditary hemorrhagic telangiectasia. Laryngoscope 114:779-781, 2004.
19. Saunders W. Hereditary hemorrhagic telangiectasia: Effective treatment of epistaxis by septal dermoplasty. Acta Otolaryngol 58:497-502, 1964.
20. Hitchings AE, Lennox PA, Lund VJ, and Howard DJ. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 19:75-78, 2005.
21. Hosni AA, and Innes AJ. Hereditary haemorrhagic telangiectasia: Young's procedure in the management of epistaxis. J Laryngol Otol 108:754-757, 1994.
22. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66-67, 2000.
23. Rebeiz EE, Bryan DJ, Ehrlichman RJ, and Shapshay SM. Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease. Ann Plast Surg 35:208-213, 1995.
24. Haye R, Austad J. Hereditary haemorrhagic telangiectasia-Argon laser. Rhinology 29:5-9, 1991.
25. Fiorella ML, Ross D, Henderson KJ, and White RI Jr. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope 115:301-305, 2005.
26. Lesnik GT, Ross DA, Henderson KJ, et al. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation. Am J Rhinol 21:312-315, 2007.
27. McCaffrey TV, Kern EB, and Lake CF. Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases. Arch Otolaryngol 103:627-630, 1977.
28. Ulso C, Vase P, and Stoksted P. Long-term results of dermatoplasty in the treatment of hereditary haemorrhagic telangiectasia. J Laryngol Otol 97:223-226, 1983.
29. Bridger GP, and Bridger GP. Hereditary hemorrhagic telangiectasia. A new dermoplasty technique. Arch Otolaryngol Head Neck Surg 118:992-993, 1992.
30. Ichimura K, Tanaka H, Yamamoto Y, et al. Nasal dermoplasty for Japanese hereditary hemorrhagic telangiectasia. Auris Nasus Larynx 33:423-428, 2006.